Related references
Note: Only part of the references are listed.Nicotine Induces Resistance to Chemotherapy by Modulating Mitochondrial Signaling in Lung Cancer
Jingmei Zhang et al.
AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY (2009)
Bcl-2 family proteins: The sentinels of the mitochondrial apoptosis pathway
W. Wei-Lynn Wong et al.
IUBMB LIFE (2008)
Randomized phase II study of carboplatin and etoposide with or without the bcl-2 antisense oligonucleotide oblimersen for extensive-stage small-cell lung cancer:: CALGB 30103
Charles M. Rudin et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
Expanding circle of inhibition: Small-molecule inhibitors of Bcl-2 as anticancer cell and antiangiogenic agents
Benjamin D. Zeitlin et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
Expression patterns and prognostic value of Bag-1 and Bcl-2 in breast cancer
Yasmine Nadler et al.
BREAST CANCER RESEARCH (2008)
Treatment of non-small cell lung cancer, stage IV - ACCP evidence-based clinical practice guidelines (2nd edition)
Mark A. Socinski et al.
CHEST (2007)
Survivin expression in non-small-cell lung carcinomas: Correlation with apoptosis and other apoptosis-related proteins, clinicopathologic prognostic factors and prognosis
Emine Cagnur Ulukus et al.
APPLIED IMMUNOHISTOCHEMISTRY & MOLECULAR MORPHOLOGY (2007)
Influence of Bcl-2 family members on the cellular response of small-cell lung cancer cell lines to ABT-737
Stephen K. Tahir et al.
CANCER RESEARCH (2007)
Overcoming the radioresistance of prostate cancer cells with a novel Bcl-2 inhibitor
J. An et al.
ONCOGENE (2007)
Paclitaxel-carboplatin alone or with bevacizumab for non-small-cell lung cancer
Alan Sandler et al.
NEW ENGLAND JOURNAL OF MEDICINE (2006)
The BH3 mimetic ABT-737 targets selective Bcl-2 proteins and efficiently induces apoptosis via Bak/Bax if Mcl-1 is neutralized
Mark F. van Delft et al.
CANCER CELL (2006)
Mitochondrial factors with dual roles in death and survival
W. -C Cheng et al.
ONCOGENE (2006)
Bax, bcl-2 and c-kit expression in non-small-cell lung cancer and their effects on prognosis
A. Yaren et al.
INTERNATIONAL JOURNAL OF CLINICAL PRACTICE (2006)
Expression and prognostic implications of apoptosis-related proteins in locally unresectable non-small cell lung cancers
E Fokkema et al.
LUNG CANCER (2006)
HA14-1, a small molecule Bcl-2 antagonist, induces apoptosis and modulates action of selected anticancer drugs in follicular lymphoma B cells
J Skommer et al.
LEUKEMIA RESEARCH (2006)
Automated quantitative analysis (AQUA) of in situ protein expression, antibody concentration, and prognosis
A McCabe et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2005)
Bcl-2 promotes invasion and lung metastasis by inducing matrix metalloproteinase-2
J Choi et al.
CANCER RESEARCH (2005)
An inhibitor of Bcl-2 family proteins induces regression of solid tumours
T Oltersdorf et al.
NATURE (2005)
Prognostic value of immunohistochemical expression of p53, bax, Bcl-2 and Bcl-x(L) in resected non-small-cell lung cancers
AM Groeger et al.
HISTOPATHOLOGY (2004)
Antitumor efficacy of oblimersen Bcl-2 antisense oligonucleotide alone and in combination with vinorelbine in xenograft models of human non-small cell lung cancer
YP Hu et al.
CLINICAL CANCER RESEARCH (2004)
X-tile: A new bio-informatics tool for biomarker assessment and outcome-based cut-point optimization
RL Camp et al.
CLINICAL CANCER RESEARCH (2004)
The clinical relevance of Bcl-2, Rb and p53 expression in advanced non-small cell lung cancer
V Gregorc et al.
LUNG CANCER (2003)
Prognostic significance of bcl-2 expression in resected pN2 non-small cell lung cancer
M Tomita et al.
EUROPEAN JOURNAL OF SURGICAL ONCOLOGY (2003)
Proteomic patterns of tumour subsets in non-small-cell lung cancer
K Yanagisawa et al.
LANCET (2003)
Role of Bcl-2 as a prognostic factor for survival in lung cancer: a systematic review of the literature with meta-analysis
B Martin et al.
BRITISH JOURNAL OF CANCER (2003)
Expression of bcl-2 protein is associated with shorter survival in nonsmall cell lung carcinoma
CI Huang et al.
CANCER (2003)
Risk of recurrence in patients with surgically resected stage I non-small cell lung carcinoma -: Histopathologic and immunohistochemical analysis
C Poleri et al.
CHEST (2003)
Automated subcellular localization and quantification of protein expression in tissue microarrays
RL Camp et al.
NATURE MEDICINE (2002)
Phase III randomized trial comparing three platinum-based doublets in advanced non-small-cell lung cancer
GV Scagliotti et al.
JOURNAL OF CLINICAL ONCOLOGY (2002)
Prognostic value of immunohistochemical expressions of p53, HER-2/neu, and bcl-2 in stage I non-small-cell lung cancer
H Han et al.
HUMAN PATHOLOGY (2002)
Apoptosis and bcl-2 expression as predictors of survival in radiation-treated non-small-cell lung cancer
JH Hwang et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2001)
Share Paper
